FERRITIN IN THE DIAGNOSIS OF GASTROINTESTINAL CANCER IN PATIENTS WITH INVOLUNTARY WEIGHT LOSS

(1) Colentina Clinical Hospital

(2) I. Cantacuzino National Institute of Research and Development in Microbiology/Immunology



This item was part of the Other Lower GI Disorders I session at UEG Week Stockholm 2011

This item can be cited as: Gut 2011; 60 (Suppl 3) A202